Seek Returns logo

A vs. PHG: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at A and PHG, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

A is a standard domestic stock, while PHG trades as New York Registered Shares, providing U.S. investors with a way to invest in the foreign-based company.

SymbolAPHG
Company NameAgilent Technologies, Inc.Koninklijke Philips N.V.
CountryUnited StatesNetherlands
GICS SectorHealth CareHealth Care
GICS IndustryLife Sciences Tools & ServicesHealth Care Equipment & Supplies
Market Capitalization41.68 billion USD26.89 billion USD
ExchangeNYSENYSE
Listing DateNovember 18, 1999March 17, 1980
Security TypeCommon StockNY Reg Shrs

Historical Performance

This chart compares the performance of A and PHG by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

A vs. PHG: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolAPHG
5-Day Price Return0.31%-2.80%
13-Week Price Return23.17%2.61%
26-Week Price Return27.20%14.11%
52-Week Price Return9.34%-2.76%
Month-to-Date Return0.31%2.53%
Year-to-Date Return9.29%-0.25%
10-Day Avg. Volume1.58M1.45M
3-Month Avg. Volume1.67M1.42M
3-Month Volatility29.31%23.06%
Beta1.280.93

Profitability

Return on Equity (TTM)

A

19.97%

Life Sciences Tools & Services Industry

Max
23.81%
Q3
11.79%
Median
7.51%
Q1
3.14%
Min
-6.95%

In the upper quartile for the Life Sciences Tools & Services industry, A’s Return on Equity of 19.97% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.

PHG

-0.18%

Health Care Equipment & Supplies Industry

Max
29.82%
Q3
15.54%
Median
9.69%
Q1
5.19%
Min
-7.98%

PHG has a negative Return on Equity of -0.18%. This indicates the company is generating a loss for its shareholders, which can be a result of unprofitability or negative shareholder equity and is often a sign of financial distress.

A vs. PHG: A comparison of their Return on Equity (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Net Profit Margin (TTM)

A

17.97%

Life Sciences Tools & Services Industry

Max
33.77%
Q3
17.97%
Median
8.97%
Q1
3.80%
Min
-11.89%

A’s Net Profit Margin of 17.97% is aligned with the median group of its peers in the Life Sciences Tools & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.

PHG

0.90%

Health Care Equipment & Supplies Industry

Max
24.65%
Q3
14.10%
Median
10.09%
Q1
5.84%
Min
-6.13%

Falling into the lower quartile for the Health Care Equipment & Supplies industry, PHG’s Net Profit Margin of 0.90% indicates weaker profitability. This means the company retains a smaller portion of each dollar in sales as profit compared to its competitors.

A vs. PHG: A comparison of their Net Profit Margin (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Operating Profit Margin (TTM)

A

21.26%

Life Sciences Tools & Services Industry

Max
31.55%
Q3
21.26%
Median
14.06%
Q1
8.54%
Min
0.11%

A’s Operating Profit Margin of 21.26% is around the midpoint for the Life Sciences Tools & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.

PHG

6.11%

Health Care Equipment & Supplies Industry

Max
31.34%
Q3
18.36%
Median
15.07%
Q1
9.62%
Min
-0.13%

PHG’s Operating Profit Margin of 6.11% is in the lower quartile for the Health Care Equipment & Supplies industry. This indicates weaker profitability from core operations, which may stem from inefficiencies or competitive pressures on pricing.

A vs. PHG: A comparison of their Operating Profit Margin (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Profitability at a Glance

SymbolAPHG
Return on Equity (TTM)19.97%-0.18%
Return on Assets (TTM)10.14%-0.08%
Net Profit Margin (TTM)17.97%0.90%
Operating Profit Margin (TTM)21.26%6.11%
Gross Profit Margin (TTM)52.92%43.85%

Financial Strength

Current Ratio (MRQ)

A

2.25

Life Sciences Tools & Services Industry

Max
4.76
Q3
2.87
Median
1.75
Q1
1.37
Min
0.57

A’s Current Ratio of 2.25 aligns with the median group of the Life Sciences Tools & Services industry, indicating that its short-term liquidity is in line with its sector peers.

PHG

1.26

Health Care Equipment & Supplies Industry

Max
4.97
Q3
2.92
Median
2.12
Q1
1.54
Min
0.86

PHG’s Current Ratio of 1.26 falls into the lower quartile for the Health Care Equipment & Supplies industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

A vs. PHG: A comparison of their Current Ratio (MRQ) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Debt-to-Equity Ratio (MRQ)

A

0.54

Life Sciences Tools & Services Industry

Max
0.95
Q3
0.70
Median
0.45
Q1
0.18
Min
0.00

A’s Debt-to-Equity Ratio of 0.54 is typical for the Life Sciences Tools & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

PHG

0.81

Health Care Equipment & Supplies Industry

Max
1.62
Q3
0.74
Median
0.47
Q1
0.15
Min
0.00

PHG’s leverage is in the upper quartile of the Health Care Equipment & Supplies industry, with a Debt-to-Equity Ratio of 0.81. While this approach can boost equity growth, it also exposes the company to greater financial vulnerability.

A vs. PHG: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Interest Coverage Ratio (TTM)

A

254.50

Life Sciences Tools & Services Industry

Max
45.00
Q3
27.84
Median
7.16
Q1
2.12
Min
-14.08

With an Interest Coverage Ratio of 254.50, A demonstrates a superior capacity to service its debt, placing it well above the typical range for the Life Sciences Tools & Services industry. This stems from either robust earnings or a conservative debt load.

PHG

1.41

Health Care Equipment & Supplies Industry

Max
56.35
Q3
24.86
Median
9.84
Q1
3.86
Min
-21.65

In the lower quartile for the Health Care Equipment & Supplies industry, PHG’s Interest Coverage Ratio of 1.41 indicates a tighter cushion for servicing debt, suggesting less financial flexibility than many of its competitors.

A vs. PHG: A comparison of their Interest Coverage Ratio (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Financial Strength at a Glance

SymbolAPHG
Current Ratio (MRQ)2.251.26
Quick Ratio (MRQ)1.710.81
Debt-to-Equity Ratio (MRQ)0.540.81
Interest Coverage Ratio (TTM)254.501.41

Growth

Revenue Growth

A vs. PHG: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

A vs. PHG: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

A

0.67%

Life Sciences Tools & Services Industry

Max
1.02%
Q3
0.67%
Median
0.32%
Q1
0.00%
Min
0.00%

A’s Dividend Yield of 0.67% is consistent with its peers in the Life Sciences Tools & Services industry, providing a dividend return that is standard for its sector.

PHG

0.01%

Health Care Equipment & Supplies Industry

Max
4.36%
Q3
1.87%
Median
0.82%
Q1
0.00%
Min
0.00%

PHG’s Dividend Yield of 0.01% is consistent with its peers in the Health Care Equipment & Supplies industry, providing a dividend return that is standard for its sector.

A vs. PHG: A comparison of their Dividend Yield (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Dividend Payout Ratio (TTM)

A

22.95%

Life Sciences Tools & Services Industry

Max
97.67%
Q3
61.34%
Median
18.53%
Q1
0.00%
Min
0.00%

A’s Dividend Payout Ratio of 22.95% is within the typical range for the Life Sciences Tools & Services industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

PHG

0.42%

Health Care Equipment & Supplies Industry

Max
160.00%
Q3
67.77%
Median
28.21%
Q1
0.00%
Min
0.00%

PHG’s Dividend Payout Ratio of 0.42% is within the typical range for the Health Care Equipment & Supplies industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

A vs. PHG: A comparison of their Dividend Payout Ratio (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Dividend at a Glance

SymbolAPHG
Dividend Yield (TTM)0.67%0.01%
Dividend Payout Ratio (TTM)22.95%0.42%

Valuation

Price-to-Earnings Ratio (TTM)

A

34.12

Life Sciences Tools & Services Industry

Max
78.22
Q3
57.42
Median
34.18
Q1
28.39
Min
1.55

A’s P/E Ratio of 34.12 is within the middle range for the Life Sciences Tools & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

PHG

146.31

Health Care Equipment & Supplies Industry

Max
67.59
Q3
41.41
Median
33.11
Q1
22.82
Min
8.68

At 146.31, PHG’s P/E Ratio is exceptionally high, exceeding the typical maximum for the Health Care Equipment & Supplies industry. This suggests the stock may be significantly overvalued compared to its peers and implies high market expectations that could be difficult to meet.

A vs. PHG: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Price-to-Sales Ratio (TTM)

A

6.13

Life Sciences Tools & Services Industry

Max
10.69
Q3
6.37
Median
4.95
Q1
3.27
Min
1.04

A’s P/S Ratio of 6.13 aligns with the market consensus for the Life Sciences Tools & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

PHG

1.32

Health Care Equipment & Supplies Industry

Max
9.49
Q3
5.41
Median
2.92
Q1
1.97
Min
0.61

In the lower quartile for the Health Care Equipment & Supplies industry, PHG’s P/S Ratio of 1.32 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.

A vs. PHG: A comparison of their Price-to-Sales Ratio (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Price-to-Book Ratio (MRQ)

A

5.12

Life Sciences Tools & Services Industry

Max
8.12
Q3
5.04
Median
3.94
Q1
2.12
Min
1.13

A’s P/B Ratio of 5.12 is in the upper tier for the Life Sciences Tools & Services industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.

PHG

1.89

Health Care Equipment & Supplies Industry

Max
10.77
Q3
6.04
Median
3.32
Q1
2.31
Min
0.83

PHG’s P/B Ratio of 1.89 is in the lower quartile for the Health Care Equipment & Supplies industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.

A vs. PHG: A comparison of their Price-to-Book Ratio (MRQ) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Valuation at a Glance

SymbolAPHG
Price-to-Earnings Ratio (TTM)34.12146.31
Price-to-Sales Ratio (TTM)6.131.32
Price-to-Book Ratio (MRQ)5.121.89
Price-to-Free Cash Flow Ratio (TTM)38.2615.32